Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of intramuscular H5N1 influenza vaccine in healthy children
jRCT2090220015Phase 2Completed
- Sponsor
- National Hospital Organization Mie National Hospital
- Start
- Apr 2008
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of inactivated Vero cell based whole virus influenza A/H5N1 in avian influenza (H5N1) (2 arms), sponsored by National Hospital Organization Mie National Hospital. Primary endpoints: Neutralizing antibody titer against H5N1 influenza virus after each vaccination, Hemagglutination inhibition antibody titer against H5 antigen after each vaccination and 1 more. Started Apr 2008; status: completed.
02
Drugs
inactivated Vero cell based whole virus influenza A/H5N1
03
Conditions
avian influenza (H5N1)
Beyond the preview
Go deeper on jRCT2090220015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2090220015.